Rating History for Atrium Therapeutics (RNA) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for RNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/10/2026 N/A New Coverage Overweight
(N/A)		 25.00
(N/A)		 14.79
(12.66)		 -14.4% Details